Like Black Swan Analysis

closed 3/31/2020 via BusinessWire

Evaluate Ltd., acquired Black Swan Analysis

synopsis: Evaluate, a company that provides trusted commercial intelligence for the pharmaceutical industry, has acquired Black Swan Analysis, a unique analysis practice that provides a turnkey solution to companies that may be resource restricted with limited capacity to provide a robust valuation for their healthcare products.
buyer: Evaluate Ltd.
Evaluate provides trusted commercial intelligence for the pharmaceutical industry. They help their clients to refine and transform their understanding of the past, present and future of the global pharmaceutical market to drive better decisions. "
target: Black Swan Analysis
Based in the UK, Black Swan Analysis is a unique analysis practice that provides a turnkey solution to companies that may be resource restricted with limited capacity to provide a robust valuation for their healthcare products.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/11/2020 via Company Press Release

BresMed Health Solutions Ltd, acquired Cello Health plc

synopsis: Arsenal Capital Partners, a specialized private equity firm investing in healthcare and industrials companies, has acquired Cello Health plc, the global healthcare-focused advisory firm. Cello Health’s capabilities and culture are highly complementary with those of BresMed, a leader in health economic research acquired by Arsenal.
buyer parent: Arsenal Capital Partners
buyer: BresMed Health Solutions Ltd
BresMed is a health economic and outcomes research consultancy that provides health economic solutions to the global pharmaceutical industry. Established in 2006, BresMed has more than 150 staff across offices in the U.K., Ireland, the Netherlands, the U.S., and India. "
target: Cello Health plc (CLLL:$204.91)
Cello Health is a global healthcare-focused advisory firm comprised of a set of leading scientific, commercial advisory and digital delivery capabilities. Cello Health enables clients to commercialise, differentiate their assets, and drive brand success.
price ($mm)
$237
rev ($mm)
$218
EBITDA ($mm)
$14
EV / rev
1.1x
EV / EBITDA
17.2x
closed 8/14/2019 via BusinessWire

SARORAS Private Capital, acquired InCrowd

synopsis: SARORAS Private Capital, a private equity investment firm focused on the technology-enabled services industry, has made a majority investment in InCrowd, pioneer of real-time data market insights in the life sciences industry.
buyer: SARORAS Private Capital
SARORAS Private Capital provides equity capital to growing companies in the technology-enabled services industry. SARORAS aspires to build industry-leading companies supporting innovative and entrepreneurial management teams to generate long-term, sustainable growth. "
target: InCrowd
InCrowd is the pioneer of the real-time, mobile first, MicroSurvey solution, delivering the top global 100 life science firms agile, primary market research. InCrowd accelerates market research and time-to-respond to insights to ensure effective brand management and strong brand health.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/4/2018 via Company Press Release

Ashfield Commercial & Medical Services, acquired SmartAnalyst, Inc.

synopsis: UDG Healthcare plc, a leading international healthcare services provider, is pleased to announce the acquisition of SmartAnalyst, a New York-based strategic commercialisation consulting and analytics business. The business will become part of Ashfield Communications.
buyer parent: UDG Healthcare plc
buyer: Ashfield Commercial & Medical Services
Ashfield is a global leader in commercialisation services for the pharmaceutical and healthcare industry. They provide field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services. "
target: SmartAnalyst, Inc.
SmartAnalyst is a US-based strategic consulting and analytics business focused on the pharmaceutical and biotech sector. SmartAnalyst provides strategic consulting services to pharmaceutical and biotech companies to support disease, asset, and portfolio level decisions.
price ($mm)[EV]
$18 [$12]
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 4/15/2015 via Company Press Release

Copernicus Marketing Consulting, will acquire Forbes Consulting Group

synopsis: Dentsu Inc. announced that its global business headquarters Dentsu Aegis Network Ltd. has reached an agreement to acquire Forbes Consulting Group and have it become part of Copernicus Marketing Consulting post acquisition. Founded in 1985, Forbes Consulting Group specializes in both quantitative and qualitative research and analysis.
buyer parent: Dentsu Inc.
buyer: Copernicus Marketing Consulting
Copernicus Marketing Consulting is a research-and-data-driven marketing consulting firm in the business of transforming companies. They use front-line experience, insights, and advanced analytics to help B2B and B2C companies develop, plan, and implement strategies that change brand trajectories. "
target: Forbes Consulting Group
The Forbes Consulting Group is a strategic and innovative market research company providing global clients with deeper levels of insight about emotions and motivations - and helping them gain strategic market advantage on the strength of these insights.
price ($mm)
rev ($mm)
$8
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 9/4/2013 via BusinessWire

Information Resources, Inc., acquired Aztec

synopsis: Information Resources, Inc. (IRI), a global leader in innovative solutions and services for consumer, retail and over-the-counter healthcare companies, announced it has acquired Aztec, a leading provider of market measurement and related services for consumer packaged goods (CPG), liquor and pharmaceutical manufacturers and retailers.
buyer parent: New Mountain Capital, LLC
buyer: Information Resources, Inc.
Information Resources, Inc. (IRi) delivers powerful market and shopper information, predictive analysis and foresight that leads to action. They go beyond the data to ignite extraordinary growth for their clients by pinpointing what matters and illuminating how it can impact their businesses. "
target parent: Dentsu Inc.
target: Aztec
Aztec provides scan-data services to consumer packaged goods retailers and manufacturers. Aztec offers computer-based information services and core offerings include data processing and reporting, leading-edge user friendly software, training and client service support.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/30/2013 via BNC Analysis

Cello Group, acquired Mash Health

synopsis: UK pharma researcher and communications consultancy Mash Health Limited and its US business Mash Health, Inc have been acquired by the UK’s Cello Group plc. Mash Health is a UK pharma researcher and communications consultancy. Mash works for clients in the pharmaceutical, nutraceutical and consumer healthcare sectors.
buyer: Cello Group (CLLL:$204.91)
Cello is a leading global insight and strategic marketing group with a primary focus on the pharmaceutical and health sectors in addition to deep expertise in a range of other high margin sectors. "
target: Mash Health
Mash Health is a UK pharma researcher and communications consultancy. Teddington-based Mash works for clients in the pharmaceutical, nutraceutical and consumer healthcare sectors, and was established in 2009.
price ($mm)
$0.99
rev ($mm)
$2
EBITDA ($mm)
EV / rev
1.0x
EV / EBITDA
closed 6/5/2015 via BNC Analysis

Measure Consumer Perspectives Inc., acquired 420 Intel Agency

synopsis: Measure Consumer Perspectives, a Louisville based mystery shopping company, has acquired 420 Intel Agency, a marijuana mystery shopping business in Colorado. The acquisition is an attempt to grow the marijuana mystery portion of Measure CP's business.
buyer: Measure Consumer Perspectives Inc.
Measure Consumer Perspectives provides solutions in the areas of mystery shopping, brand auditing, compliance checks, and field research. Measure uses traditional, mobile, geocoded, and hidden camera technologies in order to bring clients pertinent insights into the brand, customer, and experience, "
target: 420 Intel Agency
The main purpose of 420 Intel Agency's dispensary mystery shopping programs are to help dispensary owners be more competitive by providing a holistic business approach that will enable them to stay up to date with the ever changing cannabis industry and increase their bottom line.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/27/2018 via Company Press Release

Evoke Group, acquired Navience Healthcare Solutions, LLC

synopsis: Evoke Group, part of Huntsworth, announces the acquisition of New Jersey-based Navience Healthcare Solutions. Navience is a full-service market access and payer marketing agency helping clients navigate the complexities of the ever-changing market access landscape by identifying, developing and executing tailored solutions.
buyer parent: Huntsworth PLC
buyer: Evoke Group
Evoke Group is a marketing, media and communications agency designed for health and wellness. Their digital DNA, data-driven mindset and full-service offering provides a unique position in the market. "
target: Navience Healthcare Solutions, LLC
Navience Healthcare Solutions is a full service managed markets agency focused on providing pharmaceutical and healthcare companies with strategic direction and planning in the market access and payer marketing areas.
price ($mm)
$24*
rev ($mm)
$6
EBITDA ($mm)
$4
EV / rev
10.9x
EV / EBITDA
18.4x
announced 11/18/2015 via Company Press Release

Inflexion Private Equity Partners LLP, will purchase Animal & Crop Health Division from GfK Group

synopsis: GfK Group announced the agreement to sell its global animal & crop health division to a consortium consisting of Inflexion, a private equity investor, and the management led by Stephen Hearn. The division specialises in all aspects of market research in animal health, crop protection, farm machinery & equipment, seed/biotech & fertilizers.
buyer: Inflexion Private Equity Partners LLP
Inflexion Private Equity Partners LLP is a UK mid-market private equity firm, investing in high growth, entrepreneurial businesses with ambitious management teams. Investing between £15m and £75m, Inflexion provides complementary investment solutions backing buyouts, as well as minority investments."
seller: GfK Group (XTRA:GFK:$1,759.04)
The Animal & Crop Health Division of GfK Group provides market research in animal health, crop protection, farm machinery & equipment, seed/biotech & fertilizers. GfK is the trusted source of relevant market and consumer information that enables its clients to make smarter decisions.
price ($mm)
rev ($mm)
$36
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 4/7/2022 via BusinessWire

Information Resources, Inc. merged with NPD Group, Inc.,

synopsis: Information Resources, Inc. (IRI), a fast-growing global leader in innovative solutions and services for consumer, retail and media companies, and The NPD Group, a global provider of market information and advisory services in more than 20 industries, have completed their merger.
buyer parent: Hellman & Friedman LLC
buyer: NPD Group, Inc.
NPD offers data, industry expertise, and prescriptive analytics to help its clients grow their businesses in a changing world. Over 2000 companies worldwide rely on NPD to help them measure, predict, and improve performance across all channels, including brick-and-mortar and e-commerce. "
target parent: Vestar Capital Partners
target: Information Resources, Inc.
Information Resources, Inc. is a leading provider of big data, predictive analytics and forward-looking insights that help CPG companies, OTC health care organizations, retailers, financial services and media companies grow their businesses.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/14/2020 via PR Newswire

Medical Knowledge Group LLC, acquired Magnolia Innovation, LLC

synopsis: Medical Knowledge Group, LLC, an analytics-driven and technology-enabled multichannel health care marketing and communications conglomerate whose operating companies serve the biopharmaceutical industry, has acquired Magnolia Innovation, a premier market research and strategy consulting firm.
buyer parent: Court Square Capital Partners
buyer: Medical Knowledge Group LLC
Medical Knowledge Group, through its operating companies, provides specialized medical communications services, proprietary analytic solutions, and market research services to the biopharmaceutical industry. "
target: Magnolia Innovation, LLC
Magnolia Innovation is a market research and consulting firm focusing exclusively in the life sciences. Magnolia has decades of combined experience building, launching, and redefining biopharmaceutical brands to drive innovation through insights.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/16/2018 via Company Press Release

Vestar Capital Partners, will acquire Information Resources, Inc.

synopsis: Vestar Capital Partners, a private equity firm, will lead a new investment in Information Resources, Inc., a leading provider of big data, predictive analytics and forward-looking insights. Jeffrey Ansell, a Vestar Senior Advisor, will serve as Chairman of IRI. New Mountain and other existing investors are retaining a meaningful investment in IRI.
buyer: Vestar Capital Partners
Vestar Capital Partners (VCP) is a private equity firm specializing in management buyouts and growth capital investments. VCP collaborates with management teams and private owners to build long- term enterprise value, with a focus on Consumer, Healthcare, and Business Services & Industrial Products."
target parent: New Mountain Capital, LLC
target: Information Resources, Inc.
Information Resources, Inc. is a leading provider of big data, predictive analytics and forward-looking insights that help CPG companies, OTC health care organizations, retailers, financial services and media companies grow their businesses.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/30/2018 via GlobeNewswire

Ipsos S.A, will purchase Four Global Divisions from GfK Group

synopsis: Ipsos will acquire GfK Group's 4 global divisions of research: customer experience, experience innovation, health, and public affairs. Customer Experience is advising on customer satisfaction, Experience Innovation is research on user experience, Heath is research on health industry companies, and Public Affairs is research on public opinion.
buyer: Ipsos S.A (ENXTPA:IPS:$2,361.14)
Headquartered in France, Ipsos is an independent market research companies managed by research professionals. Ipsos researchers assess market potential and trends, develop brands, help clients build long-term relationships with customers, test advertising, and study audience responses. "
seller: GfK Group (XTRA:GFK:$1,759.04)
Headquartered in Germany. GfK Group is the trusted source of relevant market and consumer information that enables its clients to make smarter decisions. GfK has multiple global divisions of GfK Research, including customer experience, experience innovation, health, and public affairs.
price ($mm)
$123
rev ($mm)
$234
EBITDA ($mm)
EV / rev
0.5x
EV / EBITDA
closed 5/27/2015 via Company Press Release

The Nielsen Company, Inc., acquired Innerscope Research, Inc

synopsis: Nielsen announced that it has completed its acquisition of Innerscope Research and has renamed its combined offering as Nielsen Consumer Neuroscience. Nielsen Consumer Neuroscience offers one comprehensive suite of conscious and non-conscious research solutions on a global scale.
buyer: The Nielsen Company, Inc. (NLSN:$3,500.00)
The Nielsen Company understands the importance of knowing what consumers watch and buy. They study consumers in more than 100 countries to give you the most complete view of trends and habits worldwide. They continue to develop better solutions to meet the needs of today’s consumers. "
target parent: Life Science Angels, Inc
target: Innerscope Research, Inc
Innerscope Research, Inc., is the leader in integrated consumer neuroscience, delivering unprecedented understanding of consumer behavior that helps brands to build deeper connections and optimize product and communication performance.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/2/2013 via BusinessWire

Market Strategies International, acquired Cogent Research LLC

synopsis: Market Strategies International announced that it has acquired Cambridge, MA-based Cogent Research, a market research and strategic consulting firm that specializes in the wealth management industry. Cogent Research founders and principals, John Meunier and Christy White, will co-manage Market Strategies’ new Syndicated Division.
buyer parent: Veronis Suhler Stevenson
buyer: Market Strategies International
Market Strategies International is a market research consultancy with deep expertise in communications, consumer goods, energy, financial services, healthcare, technology and wealth management. "
target: Cogent Research LLC
Cogent Research, founded in 1996, provides custom marketing research, syndicated research products, and evidence-based consulting to leading organizations in the financial services, life sciences and consumer goods industries.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/23/2013 via PR Newswire

1-800 We Answer, Inc., acquired TMR Inc. Market Research Group

synopsis: 1-800 We Answer, www.weanswer.com, a call center network that handles millions of calls for clients, has obtained TMR Inc. Market Research Group. TMR offers telephone interviewing and consumer, industrial and medical data collection and analysis.
buyer: 1-800 We Answer, Inc.
1-800 We Answer, Inc. is a business communications solutions company whose core business support services consist of telephone answering, call center, market research, and telemarketing services to businesses, government agencies, and universities nationwide. "
target: TMR Inc. Market Research Group
TMR is an industry leader in telephone interviewing and consumer, industrial and medical data collection and analysis. This market research firm delivers "quality work at competitive prices," and has a proven track record as a full-service quantitative and qualitative research organization.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/31/2017 via Company Press Release

DrFirst, Inc., acquired VisibilityRx

synopsis: DrFirst, a pioneer in electronic prescribing, integrated medication management and secure communication for healthcare, has acquired VisibilityRx, a provider of clinical trial recruitment services to life sciences, clinical research organizations and pharmacies. Healthcare companies use VisibilityRx to effectively communicate messages to patients.
buyer: DrFirst, Inc.
DrFirst pioneers software solutions and services that provide real-time access to patient data, improve communication and collaboration at the point of care and across the patient’s circle of caregivers, and enhance the doctor’s clinical view of the patient to help drive better health outcomes. "
target: VisibilityRx
VisibilityRx is the leader in precise patient identification and communication solutions for clinical trials, risk evaluation and mitigation strategies, and market research initiatives. It is utilized by many healthcare companies to effectively communicate their messages to their patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/21/2021 via PR Newswire

Integrity Marketing Group, acquired Deft Research, LLC

synopsis: Integrity Marketing Group, LLC, the nation's largest independent distributor of life and health insurance products, has acquired Deft Research, LLC, the healthcare industry's leading source for consumer and market data.
buyer: Integrity Marketing Group
Integrity Marketing Group is America's leading independent distributor of life and health insurance products focused on serving the Senior Market. Integrity develops and distributes life and health insurance products with insurance carrier partners. "
target: Deft Research, LLC
Deft Research, headquartered in Minneapolis, Minnesota, is the leading resource for timely, reliable health insurance consumer insights and market information.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/27/2021 via BusinessWire

Press Ganey Associates, Inc., acquired Symphony Performance Health, Inc.

synopsis: Press Ganey, the national leader in health care consumer and workforce engagement, acquired SPH Analytics (SPH), the national leader in member experience measurement and engagement for the health insurance industry.
buyer: Press Ganey Associates, Inc. (PGND:$344.32)
Press Ganey offers an integrated suite of solutions that enables enterprise transformation across the patient journey. Delivered through a cutting-edge digital platform, Press Ganey solutions address safety, clinical excellence, patient experience, and workforce engagement. "
target parent: Symphony Technology Group
target: Symphony Performance Health, Inc.
SPH Analytics offers the leading healthcare measurement and analytics platform for consumer experience. Leveraging a foundation of 35 years of healthcare consumer experience data and behavioral patterns, SPH deploys an analytical and predictive approach to measure and report the consumer experience.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/31/2020 via BusinessWire

Evaluate Ltd., acquired Black Swan Analysis

synopsis: Evaluate, a company that provides trusted commercial intelligence for the pharmaceutical industry, has acquired Black Swan Analysis, a unique analysis practice that provides a turnkey solution to companies that may be resource restricted with limited capacity to provide a robust valuation for their healthcare products.
buyer: Evaluate Ltd.
Evaluate provides trusted commercial intelligence for the pharmaceutical industry. They help their clients to refine and transform their understanding of the past, present and future of the global pharmaceutical market to drive better decisions. "
target: Black Swan Analysis
Based in the UK, Black Swan Analysis is a unique analysis practice that provides a turnkey solution to companies that may be resource restricted with limited capacity to provide a robust valuation for their healthcare products.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/31/2020 via BusinessWire

Evaluate Ltd., acquired Black Swan Analysis

synopsis: Evaluate, a company that provides trusted commercial intelligence for the pharmaceutical industry, has acquired Black Swan Analysis, a unique analysis practice that provides a turnkey solution to companies that may be resource restricted with limited capacity to provide a robust valuation for their healthcare products.
buyer: Evaluate Ltd.
Evaluate provides trusted commercial intelligence for the pharmaceutical industry. They help their clients to refine and transform their understanding of the past, present and future of the global pharmaceutical market to drive better decisions. "
target: Black Swan Analysis
Based in the UK, Black Swan Analysis is a unique analysis practice that provides a turnkey solution to companies that may be resource restricted with limited capacity to provide a robust valuation for their healthcare products.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/9/2021 via Company Press Release

Telstra Health, will acquire MedicalDirector

synopsis: Telstra announced that Telstra Health has entered into a binding agreement to acquire leading GP clinical and practice management software company MedicalDirector. MedicalDirector has been trusted by healthcare practitioners for over 25 years, providing software as a service and innovation to the healthcare industry.
buyer parent: Telstra Corporation Limited
buyer: Telstra Health (ASX:TLS:$20,666.75)
Telstra Health is Australia's largest ehealth company. Telstra Health provides technology solutions that help improve the quality, efficiency and security of health services. They offer products and solutions for electronic medical records, telehealth, back office, medication management and more. "
target parent: Affinity Equity Partners
target: MedicalDirector
MedicalDirector has been trusted by healthcare practitioners for over 25 years, providing software as a service and innovation to the healthcare industry, including across electronic health records, patient and practice management, billing, scheduling, care coordination, and clinical content.
price ($mm)
$257
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2019 via BusinessWire

Xcenda, acquired Dymaxium, Inc.

synopsis: Xcenda, a part of AmerisourceBergen, announced the acquisition of Dymaxium, a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
buyer parent: AmerisourceBergen Corporation
buyer: Xcenda
Xcenda, part of AmerisourceBergen, is a strategic consultancy with 20+ years of experience applying real-world expertise in health economics and outcomes research, reimbursement, stakeholder insights, and market access consulting and communications. "
target: Dymaxium, Inc.
Dymaxium is a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/7/2016 via BNC Analysis

M3, Inc., will acquire Vidal Group

synopsis: Electra Partners’ portfolio company AXIO Group has received a binding offer from M3 Inc. to purchase Vidal Group, a European provider of reference drug information. Vidal Group provides hospitals, primary care physicians, pharmacists, and patients with on-line access to up-to-date drug databases and related treatment-based information.
buyer: M3, Inc. (TSE:2413:$1,127.03)
M3 Inc. represents the three Ms of Medicine, Media, and Metamorphosis. Their company was founded with the goal of changing the world of medicine through making full use of the power of the Internet. "
target parent: Electra Partners LLP
target: Vidal Group
Vidal Group is a leading European healthcare informatics and information systems company. Vidal Group provides hospitals, primary care physicians, pharmacists, and patients across Europe with on-line access to up-to-date drug databases and related treatment-based information.
price ($mm)
$133
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/18/2016 via BNC Analysis

Affinity Equity Partners, acquired MedicalDirector

synopsis: Leading Asian private equity firm Affinity Equity Partners has acquired Sydney-based MedicalDirector (formerly Health Communication Network) from Australia’s Primary Health Care Ltd. MedicalDirector is a leading provider of clinical and enterprise software solutions to general practitioners, medical specialists and allied health professionals.
buyer: Affinity Equity Partners
Affinity Equity Partners is an independently-owned buyout fund manager comprising primarily the former investment professionals of UBS Capital Asia Pacific. They are pioneers in buyout investments in the Asia-Pacific region, with an established and widely recognised franchise. "
target parent: Primary Health Care Limited
target: MedicalDirector
MedicalDirector has been supporting healthcare professionals and improving health outcomes for more than 20 years. They provide software for practice management, optimizing patient outcomes, and access to Australia's most comprehensive and up-to-date pharmaceutical database.
price ($mm)
$119
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/26/2015 via Company Press Release

Inovalon, Inc., will acquire Avalere Health LLC

synopsis: Inovalon, a leading technology company providing cloud-based analytics and data-driven intervention platforms to the healthcare industry, has entered into a definitive agreement to acquire Avalere Health, Inc., a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
buyer: Inovalon, Inc. (INOV:$449.36)
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. "
target: Avalere Health LLC
Avalere Health, Inc. is a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
price ($mm)
$140
rev ($mm)
$47
EBITDA ($mm)
EV / rev
3.0x
EV / EBITDA
closed 6/11/2012 via BNC Analysis

Piramal Healthcare Limited, acquired Decision Resources Group

synopsis: Piramal Healthcare Limited has completed its previously announced acquisition of Decision Resources Group, a US based company in the healthcare information segment. Decision Resources Group is a cohesive portfolio of companies that offers best in class, high-value information and insights on important sectors of the healthcare industry.
buyer parent: Piramal Group
buyer: Piramal Healthcare Limited
With assets across North America, Europe and Asia, Piramal Healthcare is one of the largest pharmaceutical custom manufacturing companies across the world. It has significant presence in the global critical care space with sales of anesthesia products to over 100 countries. "
target parent: Providence Equity Partners Inc.
target: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions.
price ($mm)
$635
rev ($mm)
$160
EBITDA ($mm)
EV / rev
4.0x
EV / EBITDA
closed 7/22/2010 via Company Press Release

CT Corsearch, acquired Edital

synopsis: CT Corsearch, the premier provider of clearance and protection solutions for trademark and brand professionals, announced it’s acquired Edital, the Questel trademark branch. This acquisition will create best-in-class solutions for managing a brand lifecycle globally—from creation to watching to protecting, maintaining and renewing a brand.
buyer parent: Wolters Kluwer NV
buyer: CT Corsearch
CT Corsearch provides high-quality, intuitive tools and expertise that trademark professionals need to effectively manage the trademark screening, search review and watching processes. "
target parent: Questel
target: Edital
Edital was established in Brussels in 1982 and acquired by Questel, a world leader in Intellectual Property in 2005. Its sole purpose has been to create global solutions for the Intellectual Property professional.
price ($mm)
rev ($mm)
$8
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 9/27/2007 via PR Newswire

Thomson Pharma, acquired Prous Science

synopsis: The Thomson Corporation, a leading provider of information solutions to business and professional customers worldwide, today announced that it has acquired Prous Science, a global leader in the provision of life sciences information solutions. Prous Science will become part of Thomson Scientific.
buyer parent: The Thomson Corporation
buyer: Thomson Pharma (:$1,876.89)
Thomson Scientific & Healthcare provides integrated information solutions to researchers and librarians, physicians and pharmacists, and other professionals worldwide. "
target: Prous Science
Prous Science is a trusted source of information on which science depends to discover safer and more effective medicines. The company's products have evolved through the years from print journals to sophisticated electronic products incorporating the latest advances in IT.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/15/2007 via Company Description

MergerMarket, acquired Infinata, Inc.

synopsis: In September 2007, Mergermarket acquired Infinata, an information solutions and marketing analytics provider to the global financial service, life science, and high technology industries.
buyer parent: Pearson plc
buyer: MergerMarket
MergerMarket, part of Pearson's Financial Times Group, is an unparalleled, independent M&A intelligence tool used by the world's foremost financial institutions to originate deals. It provides proprietary intelligence on potential deal flow, potential mandates and valuations. "
target: Infinata, Inc.
Infinata is an innovative provider of information solutions and marketing analytics to the global financial service, life science, and high-tech industries. Our information suites include: BioPharm Insight, High Net Worth Insight, and Corporate Tracker.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/7/2019 via BNC Analysis

Inflexion Private Equity Partners LLP, will acquire Pharmaspectra

synopsis: Inflexion Private Equity, a UK mid-market private equity firm, will acquire Pharmaspectra, a global provider of medical affairs data to the pharmaceutical and biotech industry. Pharmaspectra offers the world's largest database for medical scientific literature and biomedical literature.
buyer: Inflexion Private Equity Partners LLP
Inflexion is a UK mid-market private equity firm. They invest in high growth, entrepreneurial businesses and work with them to accelerate growth. Inflexion’s flexible approach allows it to back both majority and minority investments, typically investing £10m to £150m of equity in each deal. "
target: Pharmaspectra
Pharmaspectra is a global provider of medical affairs data to the pharmaceutical and biotech industry. Pharmaspectra offers the world's largest database for medical scientific literature and biomedical literature. Their web-based solutions analyze data across the entire medical continuum.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/3/2013 via Company Press Release

JISC Collections, acquired SpringerProtocols

synopsis: Springer announced that JISC Collections has purchased the archive content of SpringerProtocols; the world’s largest database of life sciences protocols. SpringerProtocols contains more than 31,000 protocols, most of which come from the classic book series “Methods in Molecular Biology”.
buyer: JISC Collections
JISC Collections supports the procurement of digital content for education and research in the UK. They are uniquely placed to provide members with: expertise in negotiating and procurement, within the scholarly communications sector. "
target parent: EQT
target: SpringerProtocols
SpringerProtocols combines the world’s largest collection of life sciences and bio-medicine protocols with advanced search functionality. Used primarily in the life sciences, the protocols provide sets of instructions that allow scientists to recreate experiments in their own laboratories.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/7/2013 via Wall Street Journal

Wilmington Group plc, acquired NHiS Ltd

synopsis: Wilmington Group plc, the provider of Information, Compliance, and Education to professional markets announced the acquisition of the entire issued and to be issued share capital of NHiS Limited. NHiS is a leading provider of business intelligence, data analysis, workflow tools and other services to pharmaceutical companies in the UK.
buyer: Wilmington Group plc (LSE:WIL:$162.62)
Wilmington Group plc is a dynamic and expanding company providing information and training to professional business markets. Their businesses enable professionals and their organizations to perform better by providing quality, relevant and reliable information, education and knowledge. "
target: NHiS Ltd
NHiS is the leading provider of market intelligence and insight to the pharmaceutical sector. NHiS’s products assist organizations in their understanding, engagement and optimization of their markets.
price ($mm)
$8.82
rev ($mm)
$3
EBITDA ($mm)
EV / rev
5.2x
EV / EBITDA
closed 9/13/2011 via PR Newswire

ImpactRx, Inc., acquired TargetRx, Inc.

synopsis: ImpactRx, a Symphony Technology Group company and the pioneer in measuring the impact of promotion on physician prescribing behavior, announced that it has acquired 100% of TargetRx, Inc., a leading provider of insight into the drivers of physician behavior for pharmaceutical companies.
buyer parent: Symphony Technology Group
buyer: ImpactRx, Inc.
ImpactRx is the leading provider of consultative and analytically-based promotional effectiveness solutions to the healthcare industry. ImpactRx's ImpactData™ is the industry’s sole source of continuous-capture market promotion and physician treatment data. "
target: TargetRx, Inc.
TargetRx, Inc. is a leading provider of insight into the drivers of physician behavior for pharmaceutical companies. The company offers a suite of solutions from pipeline to patent expiry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/3/2016 via PR Newswire

IMS Health Incorporated, acquired AlphaImpactRx, Inc

synopsis: Symphony Technology Group announced the closing of the sale of AlphaImpactRx, a leading provider of primary research and analytics-based insight for biopharmaceutical and consumer health companies to IMS Health, a global information and technology services company serving the healthcare industry.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
target parent: Symphony Technology Group
target: AlphaImpactRx, Inc
AlphaImpactRx is the leading provider of primary research-based insights, analytics and solutions to pharmaceutical, consumer health and medical device companies. They provide market research to help its global healthcare clients make informed and business decisions to market their products.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/18/2011 via PR Newswire

Symphony Technology Group, acquired ImpactRx, Inc.

synopsis: ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior, announced that Symphony Technology Group (STG), has acquired a majority ownership interest in the Company. STG is a leading private equity firm with a strategic focus on data, analytics and technology-enabled services companies.
buyer: Symphony Technology Group
Symphony Technology Group (STG) is a strategic private equity firm with the mission of investing in and building great software and services companies. STG also provides transformation expertise to enable its companies to deliver maximum value to its clients. "
target: ImpactRx, Inc.
ImpactRX annually captures three-million treatment decisions, fueling its unique ImpactData™ industry database. ImpactRx leverages this unprecedented intelligence with custom research and analytics to provide insightful solutions to pharmaceutical marketing and sales decision makers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 2/28/2020 via Company Press Release

JMDC Inc., will acquire MeCompany

synopsis: JMDC Inc., a company that provides medical data statistics, life insurance data statistics, health data platform management, and other services, will be acquiring MeCompany, a database company for medical institutions, dispensing pharmacies, and nursing care establishments using the SCUEL database.
buyer: JMDC Inc. (TSE:4483:$162.26)
JMDC Inc. offers information services. The Company provides medical data statistics, life insurance data statistics, health data platform management, and other services. JMDC provides its services throughout Japan. "
target: MeCompany
Based in Japan, MeCompany is a database company for medical institutions, dispensing pharmacies, and nursing care establishments using the SCUEL database. MeCompany strives to develop a matching service that creates encounters between medical institutions and pharmacies and patients
price ($mm)
$9.76
rev ($mm)
$2
EBITDA ($mm)
EV / rev
4.4x
EV / EBITDA
closed 1/6/2017 via PR Newswire

InVitae, acquired AltaVoice

synopsis: Invitae Corporation has acquired AltaVoice, a privately owned, patient-centered data company with a global platform for collecting, curating, coordinating, and delivering safeguarded data from patients and clinicians.
buyer: InVitae (NVTA:$460.45)
Invitae, a genetic information company, is aggregating the worlds genetic tests into a single service with better quality, faster turnaround time and lower price than most single-gene tests today. Our mission is to bring genetic information into routine medical practice to improve the quality of hea"
target: AltaVoice
AltaVoice is a patient-centered data company with an innovative story and business model that optimizes the search for better treatments for diseases. They build and host Patient Insights Networks (PINs).
price ($mm)
$5.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/3/2014 via BusinessWire

Fitzroy Health, acquired RJ Health Systems

synopsis: Fitzroy Health, LLC announced the acquisition of RJ Health Systems International, LLC. RJ Health Systems develops products and services that are designed to offer useable knowledge of pharmaceuticals, including cost, billing, management, and utilization review with the goal of promoting the safe and appropriate use of medication.
buyer: Fitzroy Health
Fitzroy Health is an investment and management firm that helps high potential healthcare companies reach scale by investing capital, managing execution, and developing commercialization and expansion strategies. "
target: RJ Health Systems
RJ Health Systems develops products and services that are designed to offer useable knowledge of pharmaceuticals, including cost, billing, management, and utilization review with the goal of promoting the safe and appropriate use of medication.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/23/2013 via BNC Analysis

Optum, acquired Humedica

synopsis: Optum has acquired Humedica. Humedica is the clinical intelligence company that powers health care providers, life sciences and research organizations to make better-informed, more confident decisions by transforming unconnected data from multiple sources into real-world insights.
buyer parent: UnitedHealth Group
buyer: Optum
Optum, through its subsidiaries, provides information and technology-enabled health services. It offers health management solutions that address the physical, mental, and financial needs of individuals and organizations. "
target: Humedica
Humedica is the clinical intelligence company that powers health care providers and life sciences organizations to make better-informed, more confident decisions by transforming unconnected data from multiple sources into real-world insights.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/9/2012 via BNC Analysis

TechCapital Group, acquired iHealthEcon

synopsis: TechCapital Group, Life Science Unit has acquired iHealthEcon, a health economics solutions company that helps life sciences organizations plan, develop and advocate health economics to global payers through e-registry-suite.
buyer: TechCapital Group
Established in 1992, TechCapital Group is a private global investment firm that originates, structures and acts as lead equity investor in equity private placements. The R&D management consulting unit provides decision support tools to advanced scientific based engineering groups. "
target: iHealthEcon
iHealthEcon, through e-registry, offers its clients an innovative suite of decision support tools to advance market access by improving the speed and efficiency of collecting health economics and outcomes research registry data in real time to National Health Systems.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Black Swan Analysis


read more

Black Swan Analysis

Cello Health plc

InCrowd

SmartAnalyst, Inc.

Forbes Consulting Group

Aztec

Mash Health

420 Intel Agency

Navience Healthcare Solutions, LLC

GfK Group

Information Resources, Inc.

Magnolia Innovation, LLC

Information Resources, Inc.

GfK Group

Innerscope Research, Inc

Cogent Research LLC

TMR Inc. Market Research Group

VisibilityRx

Deft Research, LLC

Symphony Performance Health, Inc.

read more

Black Swan Analysis

read more

Black Swan Analysis

read more

MedicalDirector

Dymaxium, Inc.

Vidal Group

MedicalDirector

Avalere Health LLC

Decision Resources Group

Edital

Prous Science

Infinata, Inc.

Pharmaspectra

SpringerProtocols

NHiS Ltd

TargetRx, Inc.

AlphaImpactRx, Inc

ImpactRx, Inc.

MeCompany

AltaVoice

RJ Health Systems

Humedica

iHealthEcon

Geography
Matching Companies
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3.com
M3.com
M3.com is Japan's largest portal site dedicated to healthcare professionals. M3.com provides the latest medical news, overseas journal article summaries, and medical resources. The portal offers information on clinical trials and other services in the healthcare and pharmaceutical industries.
year
2021
rev ($mm)
$1,724.14
EBITDA ($mm)
$657.72
EBIT ($mm)
$604.18
Net Income ($mm)
$581.12
Employees
8249
  • drill down
  • watch
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3, Inc.
M3 Inc. represents the three Ms of Medicine, Media, and Metamorphosis. Their company was founded with the goal of changing the world of medicine through making full use of the power of the Internet.
year
2019
rev ($mm)
$1,127.03
EBITDA ($mm)
$319.84
EBIT ($mm)
$286.78
Net Income ($mm)
$193.56
Employees
6024
  • drill down
  • watch